
|Articles|July 15, 2022
News Roundup: July 11 to July 15
Author(s)Miranda Hester
Your weekly roundup of the latest news from Drug Topics®.
Advertisement
FDA Issues EUA for Novavax COVID-19 Vaccine, Adjuvanted
Adults aged 18 and older are eligible to receive the vaccine.
Helping Patients Manage Diabetes Burnout
Over time, the emotional burden of managing the disease can become overwhelming.
Prescription to OTC Switches A Boon for Pharmacy Front End
Medications that switch from prescription-only to OTC can be stocked in the pharmacy’s front end.
Specialty Drug Pipeline Updates for 2022
The specialty drug pipeline includes first- and next-in- class drugs across the oncology and immunology spaces.
Novel, Dual-Targeted Treatment for T2D Is FDA Approved
Tirzepatide is a once-weekly subcutaneous injection to treat type 2 diabetes in conjunction with diet and exercise.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
The Drug Price Paradox: PBMs, Pharmacies, and the Path to Affordability
2
Zepbound Lowers Health Care Costs in Older Adults With Obesity
3
How mRNA and Protein-Based COVID-19 Vaccines Work
4
Updated Guideline Refines Approach to Migraine Prevention in Adults
5






































